Translation rights for Dr. Robert Lufkin's New York Times bestselling book, 'Lies I Taught in Medical School,' have been sold for Korean, Polish, Bulgarian, Hungarian, and Czech language editions, with interest from numerous other countries. The sales, reported by BenBella Books Rights Manager Rachel Phares, signal growing international demand for the book's controversial perspective on modern medicine.
The book argues that modern medicine has fundamentally misunderstood and mishandled several key areas of health, particularly chronic diseases. Dr. Lufkin presents evidence that conditions like obesity, diabetes, and hypertension share common root causes that are largely overlooked by conventional medical systems. He details how he personally reversed four chronic diseases using lifestyle interventions and provides readers with instructions to apply similar approaches.
"I am very excited about my book 'Lies I Taught in Medical School' going internationally, which will allow it to reach so many more people with the life transforming and life saving message that most of the chronic diseases that we face can be delayed or even reversed by the lifestyle choices we make every day," said Dr. Lufkin. He emphasizes tools based on nutrition, exercise, sleep, and stress management that he employed for himself and his patients.
Glenn Yeffeth, Publisher of BenBella Books, noted the work's success, stating, "Dr. Lufkin employs the latest science to challenge the conventional wisdom and show readers how to make a long-term breakthrough in their health." The publisher's website, https://www.benbellabooks.com, highlights their twenty-year history and numerous bestsellers.
Literary agent Alan Morell of Creative Management Partners, who represented Dr. Lufkin, described the book as "a true to life guide and cautionary tale" addressing global epidemics of chronic diseases. Morell's agency, detailed at http://www.creativemanagementpartners.com, has extensive experience in rights management. He expressed pleasure that the book continues to sell in North America while expanding to Europe, Asia, and South America.
Dr. Lufkin's credentials include serving as a full professor at both UCLA and USC medical schools, authoring over 200 peer-reviewed papers, and holding leadership positions in professional medical societies. His work has practical applications, including the invention of the MR-compatible 'Lufkin Needle' used worldwide. He currently focuses on the applied science of longevity as a Clinical Professor of Radiology at USC.
The international rights sales matter because they amplify a critique of mainstream medical education and chronic disease treatment to diverse global audiences. As healthcare systems worldwide grapple with rising rates of obesity, diabetes, and hypertension, Lufkin's message challenges entrenched practices and offers an alternative framework centered on lifestyle modification. The expansion into multiple language markets indicates that this critique resonates beyond English-speaking readers, potentially influencing medical discourse, patient approaches, and public health conversations internationally. For readers, the book's wider availability provides access to controversial but scientifically-grounded perspectives that question standard medical advice, empowering individuals to reconsider the root causes of chronic illness.
